Bryce Point Capital LLC Buys Shares of 939 UnitedHealth Group Incorporated (NYSE:UNH)

Bryce Point Capital LLC purchased a new stake in UnitedHealth Group Incorporated (NYSE:UNH) during the fourth quarter, Holdings Channel.com reports. The firm purchased 939 shares of the healthcare conglomerate’s stock, valued at approximately $475,000.

A number of other institutional investors also recently added to or reduced their stakes in the stock. Norges Bank bought a new position in shares of UnitedHealth Group during the 4th quarter worth approximately $6,375,744,000. Raymond James Financial Inc. acquired a new position in shares of UnitedHealth Group during the fourth quarter worth $1,914,740,000. Amundi boosted its position in shares of UnitedHealth Group by 97.2% in the 4th quarter. Amundi now owns 6,069,100 shares of the healthcare conglomerate’s stock worth $3,183,132,000 after purchasing an additional 2,991,470 shares in the last quarter. Proficio Capital Partners LLC increased its position in UnitedHealth Group by 76,830.4% during the 4th quarter. Proficio Capital Partners LLC now owns 1,888,641 shares of the healthcare conglomerate’s stock valued at $955,388,000 after buying an additional 1,886,186 shares in the last quarter. Finally, Franklin Resources Inc. grew its stake in shares of UnitedHealth Group by 10.7% during the fourth quarter. Franklin Resources Inc. now owns 8,923,770 shares of the healthcare conglomerate’s stock worth $4,514,178,000 after acquiring an additional 861,854 shares during the last quarter. Institutional investors own 87.86% of the company’s stock.

Insider Transactions at UnitedHealth Group

In related news, Director Timothy Patrick Flynn acquired 1,000 shares of the business’s stock in a transaction on Friday, January 17th. The shares were bought at an average price of $511.57 per share, with a total value of $511,570.00. Following the completion of the acquisition, the director now owns 4,500 shares in the company, valued at $2,302,065. This trade represents a 28.57 % increase in their ownership of the stock. The acquisition was disclosed in a legal filing with the SEC, which can be accessed through this link. Corporate insiders own 0.33% of the company’s stock.

Wall Street Analyst Weigh In

A number of analysts recently commented on UNH shares. Oppenheimer lifted their target price on shares of UnitedHealth Group from $610.00 to $640.00 and gave the stock an “outperform” rating in a research note on Friday, December 6th. KeyCorp reissued an “overweight” rating and issued a $650.00 target price on shares of UnitedHealth Group in a research report on Friday, January 17th. Truist Financial dropped their price target on UnitedHealth Group from $625.00 to $610.00 and set a “buy” rating on the stock in a research note on Monday, January 6th. StockNews.com raised UnitedHealth Group from a “hold” rating to a “buy” rating in a report on Thursday, January 23rd. Finally, HSBC raised shares of UnitedHealth Group from a “hold” rating to a “buy” rating and set a $595.00 price target for the company in a research report on Friday, January 10th. Twenty analysts have rated the stock with a buy rating and two have assigned a strong buy rating to the stock. According to data from MarketBeat, the stock currently has an average rating of “Buy” and a consensus target price of $629.32.

UnitedHealth Group Stock Down 2.9 %

UnitedHealth Group stock opened at $524.94 on Friday. UnitedHealth Group Incorporated has a 12 month low of $436.38 and a 12 month high of $630.73. The company has a debt-to-equity ratio of 0.74, a current ratio of 0.83 and a quick ratio of 0.91. The business has a 50 day simple moving average of $509.24 and a 200-day simple moving average of $542.37. The stock has a market capitalization of $480.17 billion, a PE ratio of 33.87, a price-to-earnings-growth ratio of 1.37 and a beta of 0.62.

UnitedHealth Group (NYSE:UNH) last posted its quarterly earnings data on Thursday, January 16th. The healthcare conglomerate reported $6.81 EPS for the quarter, beating the consensus estimate of $6.74 by $0.07. The firm had revenue of $100.81 billion during the quarter, compared to the consensus estimate of $101.60 billion. UnitedHealth Group had a return on equity of 26.69% and a net margin of 3.60%. The firm’s revenue was up 6.8% compared to the same quarter last year. During the same period in the prior year, the company earned $5.83 EPS. On average, analysts anticipate that UnitedHealth Group Incorporated will post 29.54 EPS for the current fiscal year.

UnitedHealth Group Announces Dividend

The firm also recently declared a quarterly dividend, which was paid on Tuesday, March 18th. Shareholders of record on Monday, March 10th were issued a dividend of $2.10 per share. This represents a $8.40 dividend on an annualized basis and a yield of 1.60%. The ex-dividend date was Monday, March 10th. UnitedHealth Group’s dividend payout ratio (DPR) is 54.19%.

About UnitedHealth Group

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.